128 related articles for article (PubMed ID: 31564650)
1. Ovarian stimulation for oocyte vitrification does not modify disease-free survival and overall survival rates in patients with early breast cancer.
Muñoz E; Domingo J; De Castro G; Lorenzo I; García-Velasco JA; Bellver J; Pellicer A; Garrido N
Reprod Biomed Online; 2019 Nov; 39(5):860-867. PubMed ID: 31564650
[TBL] [Abstract][Full Text] [Related]
2. Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response.
Volodarsky-Perel A; Cohen Y; Arab S; Son WY; Suarthana E; Dahan MH; Tulandi T; Buckett W
Hum Reprod; 2019 Mar; 34(3):530-538. PubMed ID: 30689898
[TBL] [Abstract][Full Text] [Related]
3. The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review.
Rodgers RJ; Reid GD; Koch J; Deans R; Ledger WL; Friedlander M; Gilchrist RB; Walters KA; Abbott JA
Hum Reprod; 2017 May; 32(5):1033-1045. PubMed ID: 28333356
[TBL] [Abstract][Full Text] [Related]
4. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.
Abir R; Ben-Aharon I; Garor R; Yaniv I; Ash S; Stemmer SM; Ben-Haroush A; Freud E; Kravarusic D; Sapir O; Fisch B
Hum Reprod; 2016 Apr; 31(4):750-62. PubMed ID: 26848188
[TBL] [Abstract][Full Text] [Related]
5. BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro.
Grynberg M; Dagher Hayeck B; Papanikolaou EG; Sifer C; Sermondade N; Sonigo C
Hum Reprod; 2019 Feb; 34(2):374-379. PubMed ID: 30561604
[TBL] [Abstract][Full Text] [Related]
6. Ovarian reserve and response to stimulation in women undergoing fertility preservation according to malignancy type.
Lefebvre T; Mirallié S; Leperlier F; Reignier A; Barrière P; Fréour T
Reprod Biomed Online; 2018 Aug; 37(2):201-207. PubMed ID: 29784618
[TBL] [Abstract][Full Text] [Related]
7. Fertility preservation before breast cancer treatment appears unlikely to affect disease-free survival at a median follow-up of 43 months after fertility-preservation consultation.
Letourneau JM; Wald K; Sinha N; Juarez-Hernandez F; Harris E; Cedars MI; McCulloch CE; Dolezal M; Chien AJ; Rosen MP
Cancer; 2020 Feb; 126(3):487-495. PubMed ID: 31639215
[TBL] [Abstract][Full Text] [Related]
8. Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy.
Chien AJ; Chambers J; Mcauley F; Kaplan T; Letourneau J; Hwang J; Kim MO; Melisko ME; Rugo HS; Esserman LJ; Rosen MP
Breast Cancer Res Treat; 2017 Aug; 165(1):151-159. PubMed ID: 28503722
[TBL] [Abstract][Full Text] [Related]
9. [Systematic proposal of fertility preservation by mature oocyte cryopreservation for recurrent benign ovarian tumors].
Dadoun Y; Azaïs H; Keller L; d'Orazio E; Collinet P; Decanter C
Gynecol Obstet Fertil Senol; 2017 Jun; 45(6):359-365. PubMed ID: 28506797
[TBL] [Abstract][Full Text] [Related]
10. Oocyte vitrification as an efficient option for elective fertility preservation.
Cobo A; García-Velasco JA; Coello A; Domingo J; Pellicer A; Remohí J
Fertil Steril; 2016 Mar; 105(3):755-764.e8. PubMed ID: 26688429
[TBL] [Abstract][Full Text] [Related]
11. Outcome of ovarian stimulation for oocyte cryopreservation in women with Turner syndrome.
Talaulikar VS; Conway GS; Pimblett A; Davies MC
Fertil Steril; 2019 Mar; 111(3):505-509. PubMed ID: 30598170
[TBL] [Abstract][Full Text] [Related]
12. Elective and Onco-fertility preservation: factors related to IVF outcomes.
Cobo A; García-Velasco J; Domingo J; Pellicer A; Remohí J
Hum Reprod; 2018 Dec; 33(12):2222-2231. PubMed ID: 30383235
[TBL] [Abstract][Full Text] [Related]
13. Disease-free survival does not differ according to fertility preservation technique for young women with breast cancer.
Sonigo C; Amsellem N; Mayeur A; Laup L; Pistilli B; Delaloge S; Eustache F; Sifer C; Rakrouki S; Benoit A; Peigné M; Grynberg M
Fertil Steril; 2023 Mar; 119(3):465-473. PubMed ID: 36473609
[TBL] [Abstract][Full Text] [Related]
14. Ovarian response and follow-up outcomes in women diagnosed with cancer having fertility preservation: Comparison of random start and early follicular phase stimulation - cohort study.
Muteshi C; Child T; Ohuma E; Fatum M
Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():10-14. PubMed ID: 30227359
[TBL] [Abstract][Full Text] [Related]
15. Aromatase Inhibitors for Ovarian Stimulation in Patients with Breast Cancer.
Ferreiro E; de Uralde BL; Abreu R; García-Velasco JA; Muñoz E
Curr Drug Targets; 2020; 21(9):910-921. PubMed ID: 32077823
[TBL] [Abstract][Full Text] [Related]
16. Safety of fertility preservation in breast cancer patients in a register-based matched cohort study.
Rodriguez-Wallberg KA; Eloranta S; Krawiec K; Lissmats A; Bergh J; Liljegren A
Breast Cancer Res Treat; 2018 Feb; 167(3):761-769. PubMed ID: 29098528
[TBL] [Abstract][Full Text] [Related]
17. Prospective assessment of follicular growth and the oocyte cohort after ovarian stimulation for fertility preservation in 90 cancer patients versus 180 matched controls.
Decanter C; Robin G; Mailliez A; Sigala J; Morschhauser F; Ramdane N; Devos P; Dewailly D; Leroy-Martin B; Keller L
Reprod Biomed Online; 2018 May; 36(5):543-551. PubMed ID: 29506861
[TBL] [Abstract][Full Text] [Related]
18. Influence of stage and grade of breast cancer on fertility preservation outcome in reproductive-aged women.
Volodarsky-Perel A; Cai E; Tulandi T; Son WY; Suarthana E; Buckett W
Reprod Biomed Online; 2020 Feb; 40(2):215-222. PubMed ID: 31953011
[TBL] [Abstract][Full Text] [Related]
19. [Do controlled ovarian hyperstimulations and cryopreservations promote recurrences after breast cancer?].
Bergamini ML; Maugard CM; Mathelin C
Gynecol Obstet Fertil Senol; 2017 Mar; 45(3):172-179. PubMed ID: 28259703
[TBL] [Abstract][Full Text] [Related]
20. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
Danis RB; Pereira N; Elias RT
Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]